inovio pharmaceuticals: Live & Latest News Updates : Vimarsana.com

World Metastatic Prostate Cancer Drug Landscape Research

Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The

HPV16+ Cancer Treatment Market is Expected to Showcase Significant Growth by 2034, Assesses DelveInsight | Key Companies in the Market - Nykode Therapeutics, Roche, ISA Pharmaceuticals, Regeneron, Transgene

/PRNewswire/ -- DelveInsight's HPV16+ Cancer Market Insights report includes a comprehensive understanding of current treatment practices, HPV16+ cancer...

DelveInsight Business Research, LLP: HPV16+ Cancer Treatment Market is Expected to Showcase Significant Growth by 2034, Assesses DelveInsight | Key Companies in the Market

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Up 10.8% in March

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 2,060,000 shares, an increase of 10.8% from the February 29th total of 1,860,000 shares. Based on an average trading volume of 526,600 shares, the short-interest ratio […]

Women in Science - Maravai's Kate Broderick's fascinating story

Kate Broderick takes us on her intriguing journey - from being drawn to how science was applied within a medical setting, to the enormous challenge of working around the clock when the pandemic began.

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Hold by StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" by StockNews.com

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a research note published on Friday. A number of other research firms have also recently issued reports on INO. JMP Securities initiated coverage on Inovio Pharmaceuticals in a research note on Thursday, January 4th. They issued […]

Inovio Pharmaceuticals (NASDAQ:INO) Lifted to "Hold" at StockNews.com

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a research report released on Friday morning. Several other equities analysts also recently weighed in on INO. Royal Bank of Canada reissued a sector perform rating on shares of Inovio Pharmaceuticals in a research note on […]

Inovio Pharmaceuticals (NASDAQ:INO) Rating Reiterated by Royal Bank of Canada

Equities Research Analysts' Upgrades for March 8th (AGEN, BOX, BSX, CIEN, FM, IMMR, INO, ITI, JEF, KMT)